Human Monkeypox: Fifty-Two Years based analysis and Updates

Abstract

The growing prevalence of human monkeypox infection has developed an alarming situation worldwide. Monkeypox virus was first time found in 1958 in monkeys and later spread to humans. The first case of human monkeypox was reported in September 1970 in the Democratic Republic of the Congo. Human monkeypox was found outside Africa in the year 2003 in United States. More recently, from May 7 2022 to June 29, 2022, the monkeypox cases are swiftly spread worldwide, involving over 50 countries, and affecting 5115 people in Europe, the United Kingdom, North America, and South America, Asia, Australia, and the Middle East. The confirmed monkeypox cases in the United Kingdom from May 7, 2022 to June 29, 2022, are 1076 (21.03%); Germany 874 (17.08%); Spain 800 (15.64%); France 440 (8.60%); Portugal 391 (7.62%); United States 350 (6.84); Canada 276 (5.39%); Netherlands 257 (5.02%); Italy 159 (3.10); Belgium 117 (1.59%); Switzerland 81 (1.58%); Israel 33 (0.64%), Ireland, and 31 (0.64%). However, in about 35 countries, the cases are less than 20 in each country. The epidemiological trends of the human monkeypox infection are swiftly shifting from endemic regions to non-endemic countries. The global health authorities must take priority-based preventive measures to stop the outbreaks of monkeypox disease across the globe.
 doi: https://doi.org/10.12669/pjms.38.6.6775
 How to cite this:Meo SA, Jawaid SA. Human Monkeypox: Fifty-Two Years based analysis and Updates. Pak J Med Sci. 2022;38(6):---------. doi: https://doi.org/10.12669/pjms.38.6.6775
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Epidemiological Trends of Human Monkeypox Cases in Northern, Southern, Western, and Eastern Regions in Europe: A Cross-Sectional Study

“…Still, the COVID-19 pandemic continues, and the world is facing another public health threat of a global outbreak of monkeypox disease [ 15 ]. The number of monkeypox cases in non-endemic regions raises concerns in societies as a potential pandemic [ 1 ]. The monkeypox outbreak in non-endemic regions mainly in the European countries has received high attention around the world [ 16 ].…”

“…Presently, in 2022, the human monkeypox virus swiftly spread in non-endemic regions and has knocked on the doors of developed nations in Europe, the USA, Australia, Asia, and the Middle East [ 6 , 12 ]. The current volume of the outbreak is rapidly growing day-to-day, as the ecological spread continues across the world mainly the Europe [ 1 ].…”

“…Monkeypox (MPX) is an emerging zoonotic disease, caused by the monkeypox virus (MPXV). The swift spread of the disease has caused an alarming situation globally [ 1 ]. The MPXV is an enveloped double-stranded DNA virus, genus Orthopoxvirus, subfamily Chordopoxvirinae, and family poxviridae [ 2 ].…”

“…Europe has four major topographical regions: Western Europe, Eastern Europe, Northern Europe, and Southern Europe [ 11 ]. The sudden spread of the monkeypox disease in European regions has developed a threatening and challenging situation [ 1 ]. This study aimed to highlight the prevalence of human monkeypox outbreaks, and better understand the spread of diseases in different European countries.…”

“…Europe has four major topographical regions: Western Europe, Eastern Europe, Northern Europe, and Southern Europe [11]. e sudden spread of the monkeypox disease in European regions has developed a threatening and challenging situation [1].…”